FEDERAL COURT OF AUSTRALIA
Jele Chemists Pty Ltd v Australian Community Pharmacy Authority [2022] FCA 1445
File number(s): QUD 293 of 2022 Judgment of: COLLIER J Date of judgment: 30 November 2022 Catchwords: PRACTICE AND PROCEDURE - application for interlocutory injunction – whether applicants can demonstrate a serious question to be tried – whether the balance of convenience favours a grant of injunction – no serious question to be tried – balance of convenience does not favour grant of interlocutory injunction – application dismissed
COSTS – whether prospective third respondent entitled to costs of the interlocutory application in which another party was seeking it be joined and injuncted – whereas the prospective third respondent made a submitting appearance – whereas prospective third respondent was required to participate at hearing and made submissions of assistance to the Court – prospective third respondent entitled to costs
Legislation: Administrative Decision (Judicial Review) Act 1977 (Cth)
Federal Court of Australia Act 1976 (Cth)
National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (Cth)
Cases cited: Australian Broadcasting Corporation v O’Neill [2006] HCA 46; (2006) 227 CLR 57
Hallgath v Australian Community Pharmacy Authority [2011] FCA 1062
Minister for Immigration & Ethnic Affairs v Guo (1997) 191 CLR 559; [1997] HCA 22
Planning Act 2016 (Qld)
Rawson Finances Pty Ltd v Commissioner of Taxation [2013] FCAFC 26
SPI Electricity Pty Ltd v Australian Energy Regulator [2014] FCA 1012
Division: General Division Registry: Queensland National Practice Area: Administrative and Constitutional Law and Human Rights Number of paragraphs: 33 Date of hearing: 29 November 2022 Counsel for the First and Second Applicants: Mr C Gunson SC Solicitor for the First and Second Applicants: Robert James Lawyers Counsel for the Second Respondent: Mr T Flaherty Solicitor for the Second Respondent: Mr Michael Flaherty Counsel for the Prospective Third Respondent: Ms K Slack Solicitor for the Prospective Third Respondent: Sparke Helmore Lawyers ORDERS
QUD 293 of 2022 BETWEEN: JELE CHEMISTS PTY LTD ACN 651 116 666
First Applicant
HBPHARMACY PTY LTD ACN 652 504 044
Second Applicant
AND: AUSTRALIAN COMMUNITY PHARMACY AUTHORITY
First Respondent
GLENVALE PHARMACY PTY LTD ACN 658 020 556
Second Respondent
ORDER MADE BY:
COLLIER J
DATE OF ORDER:
30 NOVEMBER 2022
THE COURT ORDERS THAT:
1.The interlocutory application, filed by the applicants on 25 November 2022, be dismissed.
2.The applicants pay the costs of the second respondent and the Secretary, Department of Health, of and incidental to the interlocutory application, such costs to be taxed if not otherwise agreed.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
REASONS FOR JUDGMENT
COLLIER J
Before the Court is an interlocutory application filed by the first and second applicants (applicants) on 25 November 2022. By that interlocutory application, the applicants seek the following relief:
1.The Secretary, Department of Health, be joined as a respondent to this proceeding.
2.That until further order, the Secretary, Department of Health, be restrained from approving the second respondent’s application made…
Keep reading for free
Create a free CaseChat account to read Jele Chemists Pty Ltd v Australian Community Pharmacy Author... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2022] FCA 1445
- Decision Date
CaseChat Overview and Summary
The court examined the legal principles governing interlocutory injunctions, as outlined in Australian Broadcasting Corporation v O'Neill. It was noted that for an injunction to be granted, the applicant must establish a serious question to be tried, a likelihood of injury for which damages would not be an adequate remedy, and that the balance of convenience favours the injunction. The court found that the applicants had not demonstrated a serious question to be tried, primarily because they had conflated merits review with judicial review, which is impermissible. Additionally, the court was not persuaded that the balance of convenience favoured the applicants, as the second respondent's proposed pharmacy had been in the public domain for some time, and the applicants had been slow to commence proceedings. The court concluded that the interlocutory application should be dismissed.
In its reasoning, the court highlighted that the applicants had not convincingly demonstrated the speculative nature of the harm they claimed would result from the second respondent opening a pharmacy. The court also considered the applicants' delay in bringing the proceedings, which contributed to the balance of convenience not favouring the grant of an interlocutory injunction. As for costs, the court found that the Secretary, Department of Health, was entitled to costs due to their substantive participation in the proceedings, despite making a submitting appearance. The Secretary's participation was deemed beneficial to the court and the parties, leading to the conclusion that costs should be awarded to the Secretary.
The court's final orders dismissed the interlocutory application and directed the applicants to pay the costs of the second respondent and the Secretary, Department of Health, related to the interlocutory application. The costs were to be taxed if not otherwise agreed. This decision underscores the stringent criteria required for the grant of an interlocutory injunction and the importance of timely legal action.
Orders
Orders of the court
1. The interlocutory application, filed by the applicants on 25 November 2022, be dismissed.
2. The applicants pay the costs of the second respondent and the Secretary, Department of Health, of and incidental to the interlocutory application, such costs to be taxed if not otherwise agreed.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Turning to the balance of convenience, the second respondent submitted that it weighed in favour of dismissing the interlocutory application. In particular the second respondent submitted that the applicants had been aware of the second respondent’s application and intention to open a pharmacy for some time, yet had been slow to commence proceedings. The second respondent further submitted, in summary :·The damage the first applicant asserts it will suffer in the event an injunction is not granted is highly speculative, and it was fanciful to suggest customers would be “locked in”. The first applicant’s proposed premises was currently operating as a hairdresser, and therefore the “estimated 50% decline” in its business could not be calculated referable to a business that had not commenced trading;·The approval granted to the first applicant occurred in full knowledge of the recommendation that the second respondent’s application would similarly be approved; and·There was doubt as to whether the applicants would actually open pharmacies in the event the substantive proceeding was dismissed.CONSIDERATION The law regarding a grant of an interlocutory injunction is well-settled. In Australian Broadcasting Corporation v O’Neill [2006] HCA 46; (2006) 227 CLR 57, Gleeson CJ and Crennan J observed at [19] that …In all applications for an interlocutory injunction, a court will ask whether the plaintiff has shown that there is a serious question to be tried as to the plaintiff’s entitlement to relief, has shown that the plaintiff is likely to suffer injury for which damages will not be an adequate remedy, and has shown that the balance of convenience favours the granting of an injunction.(see also Gummow and Hayne JJ at [65]) I am not satisfied that the interlocutory injunctive relief sought by the applicants should be granted. This is primarily because I am not satisfied that, in ground 1(a) as pleaded by the applicants, the applicants have demonstrated that there is a serious question to be tried. As the second respondent correctly identified, that ground seeks to conflate merits review with judicial review, the former being impermissible. That this is so is plainly demonstrated by reference to r 10(3) of the Rules. Under r 10(3)(c) the first respondent need only be satisfied that proposed premises could be used for the operation of a pharmacy under relevant regulations. Satisfaction in this sense is a highly subjective concept, and cannot easily be disproved. The relevant regulations in this case were, as the applicant submitted, under the Planning Act 2016 (Qld)(Planning Act), in particular s 71 which relevantly provides:When development approval has effect71 WHEN DEVELOPMENT APPROVAL HAS EFFECT(1) Generally, a development approval starts to have effect when the approval is given, or taken to have been given, to the applicant.(2)However –a) if an appeal about the approval is started, and subject to the outcome of the appeal—the approval starts to have effect when the appeal ends; or